Study finds higher frequency of anterior segment problems and links certain ones, including neuro-ophthalmic and corneal issues, to reduced survival, highlighting the need for collaborative management strategies.
The American Academy of Ophthalmology and North American Neuro-Ophthalmology Society stress that more research is needed to determine whether the association is causal.
Optometrists have access to many new meds right now, with a flood of more on the way. Here’s a comprehensive review of what’s out now and what’s in the pipeline.
Two experts share their best “dos and don'ts” to help you confidently handle the most common scenarios across several different categories of medications.
A once-simple treatment protocol has gotten more sophisticated—and complicated—by novel drug compounds, varied dosing regimens and sustained-release delivery methods. Here’s the current state of affairs.